- February 25, 2021
Paving the Way for Cancer Health Equity
- February 25, 2021
COVID-19: Being a part of research to make a change
- February 24, 2021
Stamping Out COVID-19 in Our Community
- February 24, 2021
Smilow Shares Greenwich: Cancer Prevention and Nutrition: What's New?
- February 24, 2021Source: The New York Times
Covid-19 Live Updates: Johnson & Johnson Vaccine Protects Against Severe Illness and May Reduce Transmission, F.D.A. Analyses Find
- February 23, 2021
Bishop Kenneth Monroe: Prostate Cancer Survivor "Facing Uncertainty through Faith"
- February 23, 2021
COVID-19: Making a Difference, Together
- February 23, 2021
Tom Ficklin: Prostate Cancer Survivor "Remaining Calm in the Storm 'I Call it Thriving, Not Just Surviving'"
Yale Center for Clinical Investigation
Welcome Message from Brian R. Smith, MD and John Krystal, MD
Co-Directors of the Yale Center for Clinical Investigation
Moving Science Forward:
YCCI is the backbone of translational research at Yale. Through mentorship, the promotion of team science, and access to patient volunteers – the heroes of research – we support research that improves health.
Twitter Feed
Tonight at 5:30 PM YCCI & the Yale Cultural Ambassadors host: "COVID Community Connection: What You Need to Know About the Vaccine and COVID-19". Join us on Zoom or watch the Facebook livestream at https://t.co/NRY7TqARxj https://t.co/h8ZkFGMTWQ5 HOURS AGO
WATCH @WTNH at noon with @LisaCarberg today. @DrOnyemaOgbuagu @YaleMedicine @YaleMed @YaleIMed @yalediscovers will answer some important questions about reopening and vaccines. https://t.co/kNknFqVTm85 HOURS AGO
Scientists at @Yale have developed a new class of antiviral agents that shows promise for creating COVID-19 therapeutics — exhibiting particular effectiveness when used in tandem with the drug remdesivir. https://t.co/qy2CDM66S05 HOURS AGO
